fbpx

Select Medical appoints new leaders

Paula Wolf//September 18, 2023

Select Medical appoints new leaders

Paula Wolf//September 18, 2023

Mechanicsburg-based Select Medical Holdings Corp., a major operator of critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics and occupational health centers, announced leadership changes, effective Oct.1.

John Saich and Thomas Mullin have been promoted to co-president, while Michael Malatesta has been named executive vice president and chief financial officer.

Saich most recently served as executive vice president and chief administrative officer overseeing Select Medical’s Outpatient Rehabilitation Division and Shared Services operations. He is a 26-year veteran of the company.

Mullin joined Select Medical in 2008, holding operational leadership positions of increasing responsibility within the Critical Illness Recovery Hospital Division, including president. In 2018, his role expanded to the Inpatient Rehabilitation Hospital Division, serving as chief operating officer. That post was followed by his appointment to executive vice president of hospital operations, where he oversaw both divisions.

As of June 30, Select Medical operated 108 critical illness recovery hospitals in 28 states, 32 rehabilitation hospitals in 12 states, 1,944 outpatient rehabilitation clinics in 39 states and the District of Columbia, and 540 occupational health centers in 41 states.

Saich and Mullin will work together to further create best practices and enhance integration across the company’s vast network, to continuously improve patient access to Select Medical’s care at all levels of post-acute illness, recovery and rehabilitation.

The new executive vice president and COO, Malatesta, is a 24-year veteran of Select Medical, serving as senior vice president of finance since 2013 after holding a variety of senior finance and accounting positions within the Outpatient Rehabilitation Division. He will be responsible for the financial planning and analysis across the entire Select Medical enterprise. Malatesta will report to Martin Jackson, who has been elevated to senior executive vice president of strategic finance and operations.

“As Select Medical continues to execute its growth strategy and mission of providing exceptional care to the 99,000 patients we serve daily across our post-acute continuum, it is critical that we continue to drive high-performance momentum and create continuous trajectory for long-term success,” Select Medical Co-Founder and Executive Chairman Robert A. Ortenzio said in a release. “These executive and C-Suite appointments represent a team that is highly adept to navigate our future.”

Paula Wolf is a freelance writer